In a recent study by Fujishiro et al., A172 glioma cells were cultured according to a previously established protocol [58] to form glioma stem cell-enriched spheroids, characterized by increased expression of stem cell markers CD133 and SOX2 [59]. Here, SOX2 is linked to central nervous system cancer.